Frailty in patients undergoing transcatheter aortic valve replacement: from risk scores to frailty-based management

Andreas Tzoumas; Damianos G. Kokkinidis; Stefanos Giannopoulos; George Giannakoulas; Leonidas Palaiodimos; Dimitrios V Avgerinos; Polydoros N Kampaktsis; Robert T. Faillace

doi:10.11909/j.issn.1671-5411.2021.06.002

Volume 18 Issue 6

Jun. 2021

Turn off MathJax

Article Contents

Article Navigation > Journal of Geriatric Cardiology > 2021 > 18(6): 479-486

Please cite this article as: Tzoumas A, Kokkinidis DG, Giannopoulos S, Giannakoulas G, Palaiodimos L, Avgerinos DV, Kampaktsis PN, Faillace RT. Frailty in patients undergoing transcatheter aortic valve replacement: from risk scores to frailty-based management. J Geriatr Cardiol 2021; 18(6): 479−486. DOI: 10.11909/j.issn.1671-5411.2021.06.002

Citation:

Please cite this article as: Tzoumas A, Kokkinidis DG, Giannopoulos S, Giannakoulas G, Palaiodimos L, Avgerinos DV, Kampaktsis PN, Faillace RT. Frailty in patients undergoing transcatheter aortic valve replacement: from risk scores to frailty-based management. J Geriatr Cardiol 2021; 18(6): 479−486. DOI: 10.11909/j.issn.1671-5411.2021.06.002

Citation:

PDF( 3734 KB)

Frailty in patients undergoing transcatheter aortic valve replacement: from risk scores to frailty-based management

doi: 10.11909/j.issn.1671-5411.2021.06.002

1.
Aristotle University of Thessaloniki, Thessaloniki, Greece
2.
Department of Medicine, Jacobi Medical Center, Albert Einstein College of Medicine, Bronx, USA
3.
Division of Cardiology, Rocky Mountain Regional VA Medical Center, University of Colorado, Denver, USA
4.
First Cardiology Department, AHEPA University Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece
5.
Division of Hospital Medicine, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, USA
6.
Department of Cardiothoracic Surgery, New York-Presbyterian/Weill Cornell Medical Center, New York, USA
7.
Division of Cardiology, New York University Langone Medical Center, New York, USA

More Information

Corresponding author: damiankokki@gmail.com
Available Online: 2021-06-22
Publish Date: 2021-06-22

Abstract

FullText(HTML)

References(56)

References

[1]	Nkomo VT, Gardin JM, Skelton TN, et al. Burden of valvular heart diseases: a population-based study. Lancet 2006; 368: 1005−1011. doi: 10.1016/S0140-6736(06)69208-8
[2]	Osnabrugge RL, Mylotte D, Head SJ, et al. Aortic stenosis in the elderly: disease prevalence and number of candidates for transcatheter aortic valve replacement: a meta-analysis and modeling study. J Am Coll Cardiol 2013; 62: 1002−1012. doi: 10.1016/j.jacc.2013.05.015
[3]	Hinterbuchner L, Strohmer B, Hammerer M, et al. Frailty scoring in transcatheter aortic valve replacement patients. Eur J Cardiovasc Nurs 2016; 15: 384−397. doi: 10.1177/1474515115596640
[4]	Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 2011; 364: 2187−2198. doi: 10.1056/NEJMoa1103510
[5]	Kodali SK, Williams MR, Smith CR, et al. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med 2012; 366: 1686−1695. doi: 10.1056/NEJMoa1200384
[6]	Arangalage D, Cimadevilla C, Alkhoder S, et al. Agreement between the new EuroSCORE II, the Logistic EuroSCORE and the Society of Thoracic Surgeons score: implications for transcatheter aortic valve implantation. Arch Cardiovasc Dis 2014; 107: 353−360. doi: 10.1016/j.acvd.2014.05.002
[7]	Watanabe Y, Hayashida K, Lefèvre T, et al. Is EuroSCORE II better than EuroSCORE in predicting mortality after transcatheter aortic valve implantation? Catheter Cardiovasc Interv 2013; 81: 1053−1060. doi: 10.1002/ccd.24702
[8]	Durand E, Borz B, Godin M, et al. Performance analysis of EuroSCORE II compared to the original logistic EuroSCORE and STS scores for predicting 30-day mortality after transcatheter aortic valve replacement. Am J Cardiol 2013; 111: 891−897. doi: 10.1016/j.amjcard.2012.11.056
[9]	Piankova P, Afilalo J. Prevalence and prognostic implications of frailty in transcatheter aortic valve replacement. Cardiol Clin 2020; 38: 75−87. doi: 10.1016/j.ccl.2019.09.011
[10]	Afilalo J, Lauck S, Kim DH, et al. Frailty in older adults undergoing aortic valve replacement: the FRAILTY-AVR study. J Am Coll Cardiol 2017; 70: 689−700. doi: 10.1016/j.jacc.2017.06.024
[11]	Rogers T, Alraies MC, Moussa Pacha H, et al. Clinical frailty as an outcome predictor after transcatheter aortic valve implantation. Am J Cardiol 2018; 121: 850−855. doi: 10.1016/j.amjcard.2017.12.035
[12]	Chen MA. Frailty and cardiovascular disease: potential role of gait speed in surgical risk stratification in older adults. J Geriatr Cardiol 2015; 12: 44−56. doi: 10.11909/j.issn.1671-5411.2015.01.006
[13]	Thongprayoon C, Cheungpasitporn W, Kashani K. The impact of frailty on mortality after transcatheter aortic valve replacement. Ann Transl Med 2017; 5: 144. doi: 10.21037/atm.2017.01.35
[14]	Leng S, Chaves P, Koenig K, et al. Serum interleukin-6 and hemoglobin as physiological correlates in the geriatric syndrome of frailty: a pilot study. J Am Geriatr Soc 2002; 50: 1268−1271. doi: 10.1046/j.1532-5415.2002.50315.x
[15]	Ha FJ, Bissland K, Mandrawa C, et al. Frailty in patients with aortic stenosis awaiting intervention. Intern Med J 2021; 51: 319−326. doi: 10.1111/imj.14737
[16]	Rosenhek R, Zilberszac R, Schemper M, et al. Natural history of very severe aortic stenosis. Circulation 2010; 121: 151−156. doi: 10.1161/CIRCULATIONAHA.109.894170
[17]	Kampaktsis PN, Kokkinidis DG, Wong SC, et al. The role and clinical implications of diastolic dysfunction in aortic stenosis. Heart 2017; 103: 1481−1487. doi: 10.1136/heartjnl-2017-311506
[18]	Papanastasiou CA, Kokkinidis DG, Kampaktsis PN, et al. The prognostic role of late gadolinium enhancement in aortic stenosis: a systematic review and meta-analysis. JACC Cardiovasc Imaging 2020; 13: 385−392. doi: 10.1016/j.jcmg.2019.03.029
[19]	Papanastasiou CA, Kokkinidis DG, Jonnalagadda AK, et al. Meta-analysis of transthoracic echocardiography versus cardiac magnetic resonance for the assessment of aortic regurgitation after transcatheter aortic valve implantation. Am J Cardiol 2019; 124: 1246−1251. doi: 10.1016/j.amjcard.2019.07.036
[20]	Mamane S, Mullie L, Lok Ok Choo W, et al. Sarcopenia in older adults undergoing transcatheter aortic valve replacement. J Am Coll Cardiol 2019; 74: 3178−3180. doi: 10.1016/j.jacc.2019.10.030
[21]	Rockwood K, Song X, MacKnight C, et al. A global clinical measure of fitness and frailty in elderly people. CMAJ 2005; 173: 489−495. doi: 10.1503/cmaj.050051
[22]	Shimura T, Yamamoto M, Kano S, et al. Impact of the clinical frailty scale on outcomes after transcatheter aortic valve replacement. Circulation 2017; 135: 2013−2024. doi: 10.1161/CIRCULATIONAHA.116.025630
[23]	Schoenenberger AW, Moser A, Bertschi D, et al. Improvement of risk prediction after transcatheter aortic valve replacement by combining frailty with conventional risk scores. JACC Cardiovasc Interv 2018; 11: 395−403. doi: 10.1016/j.jcin.2017.11.012
[24]	van Mourik MS, Velu JF, Lanting VR, et al. Preoperative frailty parameters as predictors for outcomes after transcatheter aortic valve implantation: a systematic review and meta-analysis. Neth Heart J 2020; 28: 280−292. doi: 10.1007/s12471-020-01379-0
[25]	Anand A, Harley C, Visvanathan A, et al. The relationship between preoperative frailty and outcomes following transcatheter aortic valve implantation: a systematic review and meta-analysis. Eur Heart J Qual Care Clin Outcomes 2017; 3: 123−132. doi: 10.1093/ehjqcco/qcw030
[26]	Tang L, Sorajja P, Mooney M, et al. Transcatheter aortic valve replacement in patients with severe comorbidities: a retrospective cohort study. Catheter Cardiovasc Interv 2021; 97: E253−E262. doi: 10.1002/ccd.29063
[27]	Steinvil A, Buchanan KD, Kiramijyan S, et al. Utility of an additive frailty tests index score for mortality risk assessment following transcatheter aortic valve replacement. Am Heart J 2018; 200: 11−16. doi: 10.1016/j.ahj.2018.01.007
[28]	Stortecky S, Schoenenberger AW, Moser A, et al. Evaluation of multidimensional geriatric assessment as a predictor of mortality and cardiovascular events after transcatheter aortic valve implantation. JACC Cardiovasc Interv 2012; 5: 489−496. doi: 10.1016/j.jcin.2012.02.012
[29]	Hermiller JB Jr, Yakubov SJ, Reardon MJ, et al. Predicting early and late mortality after transcatheter aortic valve replacement. J Am Coll Cardiol 2016; 68: 343−352. doi: 10.1016/j.jacc.2016.04.057
[30]	Green P, Arnold SV, Cohen DJ, et al. Relation of frailty to outcomes after transcatheter aortic valve replacement (from the PARTNER trial). Am J Cardiol 2015; 116: 264−269. doi: 10.1016/j.amjcard.2015.03.061
[31]	Arnold SV, Spertus JA, Vemulapalli S, et al. Quality-of-life outcomes after transcatheter aortic valve replacement in an unselected population: a report from the STS/ACC Transcatheter Valve Therapy Registry. JAMA Cardiol 2017; 2: 409−416. doi: 10.1001/jamacardio.2016.5302
[32]	Kappetein AP, Head SJ, Généreux P, et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. J Thorac Cardiovasc Surg 2013; 145: 6−23. doi: 10.1016/j.jtcvs.2012.09.002
[33]	Yamamoto M, Shimura T, Kano S, et al. Prognostic value of hypoalbuminemia after transcatheter aortic valve implantation (from the Japanese Multicenter OCEAN-TAVI Registry). Am J Cardiol 2017; 119: 770−777. doi: 10.1016/j.amjcard.2016.11.019
[34]	Puls M, Sobisiak B, Bleckmann A, et al. Impact of frailty on short- and long-term morbidity and mortality after transcatheter aortic valve implantation: risk assessment by Katz Index of activities of daily living. EuroIntervention 2014; 10: 609−619. doi: 10.4244/EIJY14M08_03
[35]	Green P, Woglom AE, Genereux P, et al. The impact of frailty status on survival after transcatheter aortic valve replacement in older adults with severe aortic stenosis: a single-center experience. JACC Cardiovasc Interv 2012; 5: 974−981. doi: 10.1016/j.jcin.2012.06.011
[36]	Honda Y, Yamawaki M, Shigemitsu S, et al. Prognostic value of objective nutritional status after transcatheter aortic valve replacement. J Cardiol 2019; 73: 401−407. doi: 10.1016/j.jjcc.2018.11.013
[37]	Nemec U, Heidinger B, Sokas C, et al. Diagnosing sarcopenia on thoracic computed tomography: quantitative assessment of skeletal muscle mass in patients undergoing transcatheter aortic valve replacement. Acad Radiol 2017; 24: 1154−1161. doi: 10.1016/j.acra.2017.02.008
[38]	Ng TP, Feng L, Nyunt MS, et al. Nutritional, physical, cognitive, and combination interventions and frailty reversal among older adults: a randomized controlled trial. Am J Med 2015; 128: 1225−1236. doi: 10.1016/j.amjmed.2015.06.017
[39]	Verghese J, Mahoney J, Ambrose AF, et al. Effect of cognitive remediation on gait in sedentary seniors. J Gerontol A Biol Sci Med Sci 2010; 65: 1338−1343. doi: 10.1093/gerona/glq127
[40]	Binder EF, Schechtman KB, Ehsani AA, et al. Effects of exercise training on frailty in community-dwelling older adults: results of a randomized, controlled trial. J Am Geriatr Soc 2002; 50: 1921−1928. doi: 10.1046/j.1532-5415.2002.50601.x
[41]	Cesari M, Vellas B, Hsu FC, et al. A physical activity intervention to treat the frailty syndrome in older persons-results from the LIFE-P study. J Gerontol A Biol Sci Med Sci 2015; 70: 216−222. doi: 10.1093/gerona/glu099
[42]	Giné-Garriga M, Guerra M, Pagès E, et al. The effect of functional circuit training on physical frailty in frail older adults: a randomized controlled trial. J Aging Phys Act 2010; 18: 401−424. doi: 10.1123/japa.18.4.401
[43]	Gariballa S, Forster S. Dietary supplementation and quality of life of older patients: a randomized, double-blind, placebo-controlled trial. J Am Geriatr Soc 2007; 55: 2030−2034. doi: 10.1111/j.1532-5415.2007.01435.x
[44]	Pedersen JL, Pedersen PU, Damsgaard EM. Early nutritional follow-up after discharge prevents deterioration of ADL functions in malnourished, independent, geriatric patients who live alone: a randomized clinical trial. J Nutr Health Aging 2016; 20: 845−853. doi: 10.1007/s12603-015-0629-2
[45]	Cameron ID, Fairhall N, Langron C, et al. A multifactorial interdisciplinary intervention reduces frailty in older people: randomized trial. BMC Med 2013; 11: 65. doi: 10.1186/1741-7015-11-65
[46]	Bibas L, Levi M, Bendayan M, et al. Therapeutic interventions for frail elderly patients: part I. Published randomized trials. Prog Cardiovasc Dis 2014; 57: 134−143. doi: 10.1016/j.pcad.2014.07.004
[47]	Gill TM, Baker DI, Gottschalk M, et al. A program to prevent functional decline in physically frail, elderly persons who live at home. N Engl J Med 2002; 347: 1068−1074. doi: 10.1056/NEJMoa020423
[48]	Kokkinidis DG, Armstrong EJ, Giri J. Balancing weight loss and sarcopenia in elderly patients with peripheral artery disease. J Am Heart Assoc 2019; 8: e013200. doi: 10.1161/JAHA.119.013200
[49]	Ribeiro GS, Melo RD, Deresz LF, et al. Cardiac rehabilitation programme after transcatheter aortic valve implantation versus surgical aortic valve replacement: systematic review and meta-analysis. Eur J Prev Cardiol 2017; 24: 688−697. doi: 10.1177/2047487316686442
[50]	Eichler S, Salzwedel A, Reibis R, et al. Multicomponent cardiac rehabilitation in patients after transcatheter aortic valve implantation: predictors of functional and psychocognitive recovery. Eur J Prev Cardiol 2017; 24: 257−264. doi: 10.1177/2047487316679527
[51]	Völler H, Salzwedel A, Nitardy A, et al. Effect of cardiac rehabilitation on functional and emotional status in patients after transcatheter aortic-valve implantation. Eur J Prev Cardiol 2015; 22: 568−574. doi: 10.1177/2047487314526072
[52]	Guralnik JM, Simonsick EM, Ferrucci L, et al. A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol 1994; 49: M85−M94. doi: 10.1093/geronj/49.2.M85
[53]	Puri R, Iung B, Cohen DJ, et al. TAVI or no TAVI: identifying patients unlikely to benefit from transcatheter aortic valve implantation. Eur Heart J 2016; 37: 2217−2225. doi: 10.1093/eurheartj/ehv756
[54]	Nishimura RA, Otto CM, Bonow RO, et al. 2017 AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 2017; 135: e1159−e1195. doi: 10.1161/CIR.0000000000000503
[55]	Otto CM, Kumbhani DJ, Alexander KP, et al. 2017 ACC expert consensus decision pathway for transcatheter aortic valve replacement in the management of adults with aortic stenosis: a report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol 2017; 69: 1313−1346. doi: 10.1016/j.jacc.2016.12.006
[56]	Asgar AW, Ouzounian M, Adams C, et al. 2019 Canadian cardiovascular society position statement for transcatheter aortic valve implantation. Can J Cardiol 2019; 35: 1437−1448. doi: 10.1016/j.cjca.2019.08.011